MINISTER OF SCIENCE AND TECHNOLOGY AND EARTH SCIENCES
(Dr HARSH VARDHAN)
(a), (b), (c) & (d): A Statement is laid on Table of the House.
Statement referred in reply to part (a), (b), (c) and (d) of Lok Sabha Starred Question No. 156* for answer on 27.07.2016
(a) Yes, Madam.
(b) NRDC had signed a Memorandum of Association (MoA) with Central Council for Research in Ayurvedic Sciences (CCRAS) on 03.03.2015 for licensing of the technologies developed at the research council to entrepreneurs /companies for commercial exploitation. The benefits that are likely to accrue from the MoA are the following:
• The Ayurvedic formulations and products manufactured by the licensee companies are used by the common people for treatment/management of various diseases.
• The licensing of the technologies to companies is a source of revenue in terms of lump-sum fee and royalty, which is shared between NRDC and CCRAS.
(c) Yes, Madam.
(d) NRDC has licensed an Anti-Diabetic Ayurvedic formulation for management of Diabetes, viz. ‘AYUSH-82’, developed by CCRAS and assigned to NRDC in February, 2016 to five companies / firms in India till date. The details of these during the last three years and the current year, State-wise and company-wise are as follows:
S. No. Name of Company Date of Signing of Agreement
Financial Year 2016-17
State - Uttarakhand
1. M/s Chaturbhuj Pharmaceutical Co.
SIDCUL Industrial Area, Haridwar 30-05-2016
State - Himachal Pradesh
2. Altis Life Sciences, Baddi 03-07-2016
Financial Year 2015-16
State - Uttarakhand
3. M/s LA Grande Herbs & Pharma Ltd.
SIDCUL Industrial Area, Haridwar 31-03-2016
State - Delhi
4. M/s Kudos Laboratories India Ltd. New Delhi 16-03-2016
5. M/s Dabur India Ltd,
Asaf Ali Road, New Delhi 18-02-2016
Financial Year 2014-15
NIL, as the technology was assigned to NRDC in Feb 2016
Financial Year 2013-14
NIL, as the technology was assigned to NRDC in Feb 2016
*****
Download PDF Files
